General Info
John Prendergass is an investor who focuses on early-stage digital health, biotech, and medical device companies in the greater Philadelphia area. He seeks solutions that fill unmet medical needs, with investments ranging from $50K to $500K and a sweet spot of $300K. His previous investments include OneForty in a Series A funding round. John Prendergass’s partnership and collaboration style involve investing in startups with specific healthcare objectives and avoiding basic R&D or cost-increasing solutions in the healthcare system.
Location: greater Philadelphia area
Country: United States of America
Industries:
Investment Regions: MENA
Investment Stages: pre-seed, seed
angel-individual
MENA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: Searches (Signal/NFX, LinkedIn, Technical.ly) show John Prendergass as an investor and mention previous investment in OneForty, but I could not find any dated investment activity or a verifiable date for the OneForty Series A or any other investment. Without a clear most-recent investment date I cannot determine recency; per instructions default to not-found.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of John Prendergass

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
